Pooling competencies MDR & IVDR Competence Centre BW (MIK) The Medical Device Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) pose major challenges for the companies and sectors concerned. As part of the Forum Health Region BW, the Baden-Württemberg Ministry of Economics, Labour and Tourism is providing funding to establish an MDR & IVDR Competence Centre.
Exploit opportunities, overcome challenges Facing the effects of Brexit on the healthcare industry The Economic Partnership Initiative by the Ministry for Economic Affairs, Labour and Housing Baden-Württemberg is intended to strengthen existing business relationships and to initiate new cooperations between BW and the UK. BIOPRO Baden-Württemberg supports this initiative in terms of healthcare industry-driven topics. We help companies from BW and the UK secure greater access to each other’s world-beating economic and research ecosystems.
Health Data Scenarios Shaping the future of health data Data generated by the healthcare system has enormous potential for improving the quality of patient-centered care. As part of the Health Data Scenarios project, Basel Area Business & Innovation worked with numerous experts from industry and academia in 2020 to develop ten scenarios of what future health data ecosystems could look like. These scenarios are now being discussed and validated together with experts and opinion leaders from Baden-Württemberg and Switzerland. BIOPRO Baden-Württemberg is providing support as a project partner.
Digitalisation of the healthcare system Photon-Counting (PC)-CT Consortium The PC3 consortium will set up the innovative photon-counting computed tomography technology in Baden-Württemberg at the following sites: the Freiburg Medical Centre, Tübingen University Hospital and the Mannheim University Hospital. The consortium will be working with its partner, Siemens Healthineers.
Translation in university medicine Baden-Württemberg-Center for Academic Drug Discovery BIOPRO Baden-Württemberg is supporting the establishment of the Baden-Württemberg Center for Academic Drug Discovery (BWCAD2) in 2021 and 2022.